The Western blot analysis revealed that treatment with SMIP34 leads to a decrease in the amounts of WDR18/PELP1/Rix1 complex proteins WDR18, TEX10, and LAS1L in HCC cell lines (Fig. 4C). Here, LAS1L is linked to hepatocellular carcinoma.